FDAsafety guidance83% confidence
Drug Trials Snapshots
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (lung cancer) as Janssen.
Regulatory Analysis
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots are part of an overall FDA effort to make demographic data more available and transparent.
Supporting Context
- Therapeutic area
- Oncology · NSCLC
- Sub-indication
- Lung Cancer
Related signal: Janssen's Amivantamab and Docetaxel Combo in NSCLC Enters Phase 1/2 Trials